DeepMed Research

NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Octanoic Acid for Essential Tremor

Phase 1

Completed

Conditions: Essential Tremor

First Posted Date: 2011-11-10

Last Posted Date: 2019-12-16

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 18

Registration Number: NCT01468948

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Effects of Hormone Stimulation on Brain Scans for Cushing s Disease

Early Phase 1

Completed

Conditions: Pituitary Neoplasm

First Posted Date: 2011-10-25

Last Posted Date: 2018-06-14

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 30

Registration Number: NCT01459237

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Studying Skeletal Muscle, Heart, and Diaphragm Imaging in Boys With Duchenne Muscular Dystrophy

Completed

Conditions: Muscular Dystrophy
Muscular Disease

First Posted Date: 2011-10-13

Last Posted Date: 2019-05-22

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 35

Registration Number: NCT01451281

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Bevacizumab With or Without Surgery for Adult Glioblastomas

Phase 2

Withdrawn

Conditions: Glioblastoma
Brain Neoplasm

First Posted Date: 2011-08-10

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Registration Number: NCT01413438

Brain Areas Involved in Sound and Spoken Word Memory

Terminated

Conditions: Language Disorder
Brain Mapping
Memory Disorder
Adult
Healthy

First Posted Date: 2011-06-17

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 45

Registration Number: NCT01375595

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Effect of Functional Exercise in Patients With Spinal Bulbar Muscular Atrophy

Phase 1

Completed

Conditions: Motor Neuron Disease

Interventions: Behavioral: A stretching exercise program
Behavioral: A functional exercise program

First Posted Date: 2011-06-09

Last Posted Date: 2019-12-17

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 61

Registration Number: NCT01369901

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People With Multiple Sclerosis

Phase 1

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: Mangafodipir (Teslascan)

First Posted Date: 2011-03-31

Last Posted Date: 2022-09-16

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 17

Registration Number: NCT01326715

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Structural and Functional Neuroimaging Studies of Combat Veterans

Completed

Conditions: PTSD
Traumatic Brain Injury

First Posted Date: 2011-02-15

Last Posted Date: 2019-12-16

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 81

Registration Number: NCT01296126

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Intravenous Norepinephrine for Orthostatic Hypotension

Phase 1

Completed

Conditions: Orthostatic Hypertension

Interventions: Drug: Intravenous Norepinephrine Infusion

First Posted Date: 2011-01-28

Last Posted Date: 2014-10-10

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 6

Registration Number: NCT01285908

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

PRX-00023 Therapy in Localization-Related Epilepsy

Phase 2

Terminated

Conditions: Epilepsy
Epilepsy, Temporal Lobe
Partial Epilepsy

Interventions: Drug: PRX-00023
Drug: Placebo

First Posted Date: 2011-01-24

Last Posted Date: 2018-12-07

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 12

Registration Number: NCT01281956

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy